|
Event Registration for Clinicians | Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced NSCLC — September 15, 2019, Chicago, ILThis activity is intended for radiation oncologists, medical oncologists, oncology fellows and other healthcare providers involved in the treatment of lung cancer. You are now registering as a practicing physician, fellow or other healthcare provider involved in the treatment of cancer. If you are not a clinician in practice, please register as a nonclinician. |